|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/05 | (2006.01) |
| A61K 31/05 | (2013.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61K 31/658 | (2023.05) |
| (11) | Patento numeris | 3967301 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 21206188.1 |
| Europos patento paraiškos padavimo data | 2018-09-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2022-03-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-06-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201762564834 P | 2017-09-28 | US | |
| 201862632532 P | 2018-02-20 | US |
| (72) |
BONN-MILLER, Marcel , US
TICH, Nancy , US
GUTTERMAN, Donna , US
MESSENHEIMER, John , US
SEBREE, Terri , US
|
| (73) |
Zynerba Pharmaceuticals, Inc. ,
80 W. Lancaster Avenue, Suite 300, Devon, PA 19333,
US
|
| (54) | TREATMENT OF IRRITABILITY IN AUTISM SPECTRUM DISORDER WITH CANNABIDIOL |
| TREATMENT OF IRRITABILITY IN AUTISM SPECTRUM DISORDER WITH CANNABIDIOL |